Антифосфолипидный синдром - часть 48

197

60. Montalban J, Fernandez J, Arderiu A et al.

Multiinfarct dementia associated with antiphos
pholipid antibodies. Presentation of two cases.
Med Clin (Barc) 1989; 93: 424—426. 

61. Kurita A, Hasunuma T, Mochio S,

Shimada T, Isogai Y, Kurahashi T. A young case
with multiinfarct dementia associated with lupus
anticoagulant. Intern Med 1994; 33: 373—375.

62. Westerman EM, Miles JM, Backonja M,

Sundstrom WR. Neuropathologic findings in
multiinfarct dementia associated with anticardi
olipin antibody. Evidence for endothelial injury as
the primary event. Arthritis Rheum 1992; 35:
1038—1041.

63. Agrawal BL, Foa RP. Collagen vascular

disease appearing as chorea gravidarum. Arch
Neurol 1982; 39: 92—193.

64. Herd JK, Medhi M, Uzendoski DM, Sal

divar VA. Chorea associated with systemic lupus
erythematosus: report of two cases and review of
the literature. Pediatrics 1978; 61: 308—315.

65. Asherson RA, Hughes GRV. Antiphos

pholipid antibodies and chorea. J Rheumatol
1988; 15: 377—9.

66. Cervera R, Asherson RA, Font J et al. Cho

rea in the antiphospholipid syndrome. Clinical,
radiologic, and immunologic characteristics of 50
patients from our clinics and the recent literature.
Medicine (Baltimore) 1997; 7 6: 203—12.

67. Scott TF, Hess D, Brillman J. Antiphos

pholipid antibody syndrome mimicking multiple
sclerosis clinically and by magnetic resonance
imaging. Arch Intern Med 1994; 154: 917—920.

68. Tourbah A, Clapin A, Gout O et al. Systemic

autoimmune features and multiple sclerosis: a 5
year followup study. Arch Neurol 1998; 55:
517—521.

69. Karussis D, Leker RR, Ashkenazi A, Ab

ramsky O. A subgroup of multiple sclerosis pa
tients with anticardiolipin antibodies and unusual
clinical manifestations: do they represent a new
nosological entity? Ann Neurol 1998; 44: 629—
634.

70. Roussel V, Yi F, Jauberteau MO et al. Pre

valence and clinical significance of antiphospho
lipid antibodies in multiple sclerosis: a study of 89
patients. J Autoimmun 2000; 14: 259—265.

71. SastreGarriga J, Reverter JC, Font J,

Tintore M, Espinosa G, Montalban X. Anticar

diolipin antibodies are not a useful screening tool
in a nonselected large group of patients with mul
tiple sclerosis. Ann Neurol 2001; 49: 408—411.

72. Harris EN, Gharavi AE, MackworthYoung

CG, Patel BM, Derue G, Hughes GRV. Lupoid
sclerosis: a possible pathogenetic role for
antiphospholipid antibodies. Ann Rheum Dis
1985; 44: 281—283.

73. Lavalle C, Pizarro S, Drenkard C, San

chezGuerrero J, AlarconSegovia D. Transverse
myelitis: a manifestation of systemic lupus erythe
matosus strongly associated with antiphospholipid
antibodies. J Rheumatol 1990; 17: 34—37.

74. RuizArguelles GJ, GuzmanRamos J,

FloresFlores J, GarayMartinez J. Refractory
hiccough heralding transverse myelitis in the pri
mary antiphospholipid syndrome. Lupus 1998; 7:
49—50.

75. Kovacs B, Lafferty TL, Brent LH, DeHora

tius RJ. Transverse myelopathy in systemic lupus
erythematosus: an analysis of 14 cases and review
of the literature. Ann Rheum Dis 2000; 59: 120—
124.

76. Sussman J, Leach M, Greaves M, Malia R,

DaviesJones GA. Potentially prothrombotic
abnormalities of coagulation in benign intracra
nial hypertension. J Neurol Neurosurg Psychiatry
1997; 62:229—33.

77. Leker RR, Steiner I. Anticardiolipin anti

bodies are frequently present in patients with idio
pathic intracranial hypertension. Arch Neurol
1998; 55: 817—820.

78. Kesler A, Ellis MH, Reshef T, Kott E, Ga

doth N. Idiopathic intracranial hypertension and
anticardiolipin antibodies. J Neurol Neurosurg
Psychiatry 2000; 68: 379—380.

79. Hisashi K, Komune S, Taira T, Uemura T,

Sadoshima S, Tsuda H. Anticardiolipin antibody
induced sudden profound sensorineural hearing
loss. Am J Otolaryngol 1993;14: 275—277.

80. Casoli P, Tumiati B. Cogan's syndrome: a

new possible complication of antiphospholipid
antibodies? Clin Rheumatol 1995; 14:197—198.

81. Toubi E, BenDavid J, Kessel A, Podoshin

L, Golan TD. Autoimmune aberration in sudden
sensorineural hearing loss: association with anti
cardiolipin antibodies. Lupus 1997; 6: 540—2.

82. Naarendorp M, Spiera H. Sudden sen

sorineural hearing loss in patients with systemic

ГЛАВА 7. Клинические проявления антифосфолипидного синдрома

Насонов Е.Л. Антифосфолипидный синдром

198

lupus erythematosus or lupuslike syndromes and
antiphospholipid antibodies. J Rheumatol 1998;
25: 589—92.

83. Harris EN, Englert H, Derue G, Hughes

GRV, Gharavi A. Antiphospholipid antibodies in
acute GuillainBarre; syndrome. Lancet 1983; ii:
1361—2.

84. Gilburd B, Stein M, Tomer Y et al. Autoan

tibodies to phospholipids and brain extract in
patients with the GuillainBarre syndrome: cross
reactive or pathogenic? Autoimmunity 1993; 16:
23—27.

85. Montalban J, Arboix A, Staub H et al.

Transient global amnesia and antiphospholipid
syndrome. Clin Exp Rheumatol 1989; 7: 85—87.

86. Wiechens B, Schroder JO, Potzsch B,

Rochels R. Primary antiphospholipid antibody
syndrome and retinal occlusive vasculopathy. Am
J Ophthalmol 1997; 123: 848—50.

87. Cordeiro MF, Lloyd ME, Spalton DJ,

Hughes GRV. Ischaemic optic neuropathy, trans
verse myelitis, and epilepsy in an antiphospholipid
positive patient with systemic lupus erythematosus.
J Neurol Neurosurg Psychiatry 1994; 57: 1142—3.

88. Gibbs AN, Moroney J, FoleyNolan D,

O'Connell PG. Neuromyelitis optica (Devic's syn
drome) in systemic lupus erythematosus: a case
report. Rheumatology 2002; 41: 470—1.

89. Reino S, MunozRodriguez FJ, Cervera R,

Espinosa G, Font J, Ingelmo M. Optic neuropathy
in the 'primary' antiphospholipid syndrome: report
of a case and review of the literature. Clin
Rheumatol 1997; 16: 629—31.

90. Giorgi D, Gabrieli CB, Bonomo L. The clin

icalophthalmological spectrum of antiphospho
lipid syndrome. Ocular Immunol Inflamm 1998;
6: 269—73.

91. Milanov I, Bogdanova D. Antiphospholipid

syndrome and dystoniaparkinsonism. A  case
report. Parkinsonism Relat Disord 2001;
7:139—41.

92. Kaplan SD, Chartash EK, Pizzarello  R.A.,

Furie  R.A. Cardiac manifestation of antiphos
pholipid syndrome. Amer Heart J 1992; 124:
1331—1338.

93. Насонов ЕЛ, Карпов ЮА, Алекберова ЗС

и соавт. Антифосфолипидный  синдром:  кар
диологические  аспекты. Терапевт. архив,
1993; 11: 80—86.

94. Аsherson RA, Khamashta MA, Baguley E,

et al. Myocardial infarction and antiphospholipid
antibodies in SLE and related disorders Quart J
Med 1989; 73: 1103—1115.

95. Карпов ЮА, Насонов ЕЛ, Вильчинская

МЮ, и соавт. Проявления ИБС и состояние
коронарных артерий у больных антифосфо
липидным синдромом. Терапевт. архив, 1995;
10: 27—31.

96. Kattwinkel N, Villanueva AG., Labib SB, et

al. Myocardial infarction caused by microvascu
lopathy in a patient with primary antiphospholipid
syndrome. Ann Int Med 1992; 116: 974—976.

97. Murphy JJ, Leach IH. Findings of necropsy

in the heart of a patient with anticardiolipin syn
drome. Br Heart J 1989; 62: 61—64.

98. Brown JH, Doherty CC, Allen DC, Morton

P. Fatal cardiac failure due to myocardial micro
thrombi in systemic lupus erythematosus. Br Med
J 1988; 296: 1505.

99. Nihoyannopoulos P, Gemez PM, Joshi J,

Loizou S, Walport MJ. Cardiac abnormalities in
systemic lupus erythematosus. Association with
raised anticardiolipin antibodies. Circulation
1990; 82: 369—375.

100. Leung WH, Wong KL, Lau CP, Wong CK,

Cheng CH. Association between antiphospholipid
antibodies and cardiac abnormalities in patients
with systemic lupus erythematosus. Am J Med
1990; 89: 411—419.

101. Hasnie AMA, Stoddard MF, Gleason CB,

et al. Diastolic dysfunction is a feature of the
antiphospholipid syndrome. Am Heart J 1995;
129: 1009—1113.

102. Bruce D, Bateman D, Thomas R. Left ven

tricular thrombi in a patient with the antiphospho
lipid syndrome. Br Heart J 1995; 74: 202—203.

103. Baum RA, Jundt JW. Intracardiac throm

bosis and antiphospholipid antibodies: A case
report and review of the literature. South Red J
87: 928—932.

104. Coppock MA, Safford RE, Danielson GK.

Intracardiac thrombosis, phospholipid antibodies
and twochambered right ventricle. Br Heart J
1988; 60: 455—458.

105. O'Neill D, Magaldi J, Dobkins D, Greco

T. Dissolution of intracardiac mass lesions in the
primary antiphospholipid antibody syndrome.
Arch Intern Med 1995; 155: 325—327.

199

106. O'Hickey S, Skinner C, Beattie J. Life

threatening right ventricular thrombosis in associ
ation with phospholipid antibodies. Br Heart J
1993; 70: 279—281.

107. Gertner E, Leatherman JW. Intracardiac

mural thrombus mimicking atrial myxoma in the
antiphospholipid syndrome. J Rheumatol 19:
1293—1298.

108. Nickele GA, Foster DA, Kenny D. Prima

ry antiphospholipid syndrome and mitral valve
thrombosis. Am Heart J 1994; 128: 1245—1247.

109. MartinezLevin M, Fonseca C, Arugo

MC, Maya A, Reyes PA, RuizArgelles A.
Antiphospholipid syndrome in patients with cyan
otic congenital heart disease. Clin Exp Rheumatol
1995; 13: 489—491.

110. EspinolaZavaleta N, VargasBarron J,

ColmenaresGalvis T, et al. Echocardiographic
evaluation of patients with primary antiphospho
lipid syndrome. Am Heart J 1999; 137: 973.

111. Hojnik M, George J, Ziporen L, Shoenfeld

Y. Heart valve involvement (LibmanSacks
Endocarditis) in the antiphospholipid syndrome.
Circulation 1996; 93:1579.

112. Turiel M, Muzznupappa S, Gottardi B, et

al. Evaluation of cardiac abnormalities and
embolic sources in primary antiphospholipid syn
drome by transesophageal echocardiography.
Lupus 2000; 9: 406.

113. Galve E, Ordi J, Barquiero J, et al. Valvu

lar heart disease in the primary antiphospholipid
syndrome. Ann Intern Med 1992; 116: 293—
298.

114. Chartash EK, Lans DM, Paget SA, et al.

Aortic insufficiency and mitral regurgitation in
patients with systemic lupus eruthematosus and
the antiphospholipid syndrome. Am J Med 1989;
86: 407—412.

115. Tektonidou MG, Ioannidis JP, Moyssakis

I, et al. Right ventricular diastolic dysfunction in
patients with anticardiolipin antibodies and
antiphospholipid syndrome. Ann Rheum Dis
2001; 60: 43—48.

116. Сергакова ЛМ, Фомичева ОА, Вильчин

ская МА, Алекберова ЗС, Александрова ЕН,
Карпов ЮА, Насонов ЕЛ, Атьков ОЮ. Осо
бенности поражения клапанов сердца при ан
тифосфолипидном синдроме. Клин. медицина,
1996; 9: 39—42.

117. Решетняк ТМ, Котельникова ГП, Фо

мичева ОА, и соавт. Кардиологические аспек
ты антифосфолипидного синдрома. Часть I.
Клапанные поражения сердца при первичном
и вторичном антифосфолипидном синдроме и
системной красной

волчанке.  Кардиология,

2002; 7: 38—43.

118. Petri M, Akhtar S, Branch W, et al. Evi

dencebased classification criteria for anti
phospholipid antibody syndrome (APS). Arthritis
Rheum 2003; 48 (Suppl): S364.

119. Насонов ЕЛ, Карпов ЮА, Алекберова

ЗС, Вильчинская МЮ, Фомичева ОА, Алек
сандрова ЕН, Решетняк ТМ, Клюквина НГ,
Андреев АЯ. Артериальная гипертония и ан
тифосфолипидный синдром. Терапевт. архив,
1996; 2: 37—40.

120. Sangle SR, D`Cruz DP, Jan W, et al. Renal

artery stenosis in the antiphospholipid (Hughes)
syndrome and hypertension. Ann Rheum Dis
2003; 62: 999—1002.

121. Sangle SR, D`Cruz DP, Khamashta M,

Hughes GRV. Prevalence of hypertension in 600
patients with antiphospholipid syndrome.
ACR/ARHP Annual Scientific Meeting, October
24—28, 2003; 868 (abst). 

122. Bacon MA, Bertolaccini ML, Karim Y, et

al. Hypertension in primary antiphospholipid syn
drome. ACR/ARHP Annual Scientific Meeting,
October 24—28, 2003; 870 (abst). 

123. Piette JC, Kleinknecht D, Bach JF.

Renal manifestations in the antiphospholipid syn
drome. In: The antiphospholipid syndrome.
Asherson RA, Cervera R, Piette JC, Shoenfeld Y
(eds). CRC Press. Boca Raton, New York,
London, Tokyo. 1996; 169—181.

124. Isom R, Nickolas TL, Radhakrishnan J.

Nephrologic and obstetric complications of the
antiphospholipid syndrome. Expert Opin Invest
Drugs 2002; 11: 819—829.

125. Amigo MC, GarciaTorres R, Robles M, et

al. Renal involvement in primary antiphospho
lipid syndrome. J Rheumatol 1992; 19: 1181.

126. KincaidSmith P, Fairly KF, Kloss M.

Lupus anticoagulant associated with renal throm
botic microangiopathy and pregnancyrelated
renal failure. Q J Med 1988; 258: 795.

127. Farrugia E, Torres VE, Gastineau MD, et

al. Lupus anticoagulant in systemic lupus erythe

ГЛАВА 7. Клинические проявления антифосфолипидного синдрома

Насонов Е.Л. Антифосфолипидный синдром

200

matosus: A clinical and pathological study. Am J
Kidney Dis 1992; 20: 436.

128. Nicholls K, KincaidSmith P. Antiphos

pholipid syndrome and renal thrombotic microan
giopathy. J Nephrol 1995; 8:123.

129. Asherson RA, Harris EN. Anticardiolipin

antibodiesclinical associations. Postgrad Med J
1986; 62: 1081.

130. D'Agati V, Kunis C, Williams G, et al.

Anticardiolipin antibody and renal disease. A report
of three cases. J Am Soc Nephrol 1990; 1: 777.

131. Nochy D, Daugas E, Droz D, et al. The

intrarenal vascular lesions associated with pri
mary antiphospholipid syndrome. J Am Soc
Nephrol 1999; 10: 507.

132. Griffiths MH, Papadaki L, Neild GH. The

renal pathology of primary antiphospholipid syn
drome: a distinctive form of endothelial injury.
QJM 2000; 93: 457.

133. Nzerue CM, HewanLowe K, Pierangeli

S, Harris, EN. "Black swan in the kidney": Renal
involvement in the antiphospholipid antibody syn
drome. Kidney Int 2002; 62: 733.

134. Sonpal GM, Sharma A, Miller A. Primary

antiphospholipid antibody syndrome, renal
infarction and hypertension. J Rheumatol 1993;
20: 1221.

135. Asherson RA, Lanham JG, Hull RG, et al.

Renal vein thrombosis in systemic lupus erythe
matosus: Association with the "lupus anticoagu
lant." Clin Exp Rheumatol 1984; 2:75.

136. Appel GB, Pirani CL, D'Agati V. Renal

vascular complications of systemic lupus erythe
matosus. J Am Soc Nephrol 1994; 4:1499.

137. Daugas E, Nochy D, Huong DL, et al.

Antiphospholipid syndrome nephropathy in sys
temic lupus erythematosus. J Am Soc Nephrol
2002; 13:42.

138. Asherson RA, Nobel GE, Hughes GRV.

Hypertension, renal artery stenosis and the 'pri
mary" antiphospholipid syndrome. J Rheumatol
1991; 18: 1413—1415.

139. Asherson RA, Hughes GRV, Derksen

RHWM. Renal infarction associated with
antiphospholipid antibodies in systemic lupus ery
thematosus and 'lupuslike' disease. J Urol 1988;
140: 1028.

140. Poux JM, Boudet R, Lacroix P, et al.

Renal infarction and thrombosis of the infrarenal

aorta in a 35year old man with primary
antiphospholipid syndrome. Am J Kid Dis 1996;
27: 721—725.

141. Hughson MD, Madasdy T, McCarty GA,

Stoler C, Min KW, Silva T. Renal thrombotic
microangiopathy in patients with systemic lupus
erythematosus and the antiphospholipid syn
drome. Amer J Kid Dis 1992; 20: 150—158.

142. Liao F, Mampaso F, BarciaMartin F.

Allograft membranous glomerulonephritis and
renal vein thrombosis in a patient with lupus anti
coagulation factor. Nephrol Dial Transplant
1988; 3: 684—689.

143. GarciaMartin F, DeArriba G, Carrascosa

T, et al. Anticardiolipin antibodies and lupus
anticoagulant in ESRD. Nephrol Dial Transplant
1991; 6: 543.

144. Prakash R, Miller CC 3

rd

, Suki WN. Anti

cardiolipin antibody in patients on maintenance
hemodialysis and its association with recurrent
arteriovenous graft thrombosis. Amer J Kidney
Dis 1995; 26: 347.

145. Brunet P, Aillaud MF, San Marco M, et

al. Antiphospholipids in hemodialysis patients:
Relationships between lupus anticoagulant and
thrombosis. Kidney Int 1995; 48: 794.

146. Prieto, LN, Suki, WN. Frequent hemo

dialysis graft thrombosis: Association with anti
cardiolipin antibodies. Am J Kidney Dis 1994;
23: 587.

147. Radhakrishnan J, Williams G, Appel GB,

et al. Renal transplantation in anticardiolipin
antibodypositive lupus erythematosus patients.
Am J Kidney Dis 1994; 23:286.

148. Ducloux D, Pellet E, Fournier V, et al.

Prevalence and clinical significance of antiphos
pholipid antibodies in renal transplant recipients.
Transplantation 1999; 67: 90.

149. Stone JH, Amend WJ, Criswell LA. Anti

phospholipid antibody syndrome in renal trans
plantation: Occurrence of clinical events in 96
consecutive patients with systemic lupus erythe
matosus. Am J Kidney Dis 1999; 34: 1040.

150. Moss KE. Isenberg DA. Comparison of

renal disease severity and outcome inpatients with
primary antiphospholipid antibody syndrome,
antiphospholipid syndrome secondary to systemic
lupus erythematosus (SLE) and SLE alone.
Rheumatology 2001; 40: 863—867.